Sage Products, LLC v. ChemRite CoPac, Inc.

District Court, N.D. Illinois·Decided November 12, 2021·No. 1:19-cv-05308·Unknown

Opinion

UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

SAGE PRODUCTS, LLC,

Plaintiff, No. 19 CV 5308 v. District Judge Bucklo CHEMRITE COPAC, INC., Magistrate Judge McShain Defendant.

MEMORANDUM OPINION AND ORDER

Pending before the Court is a motion by defendant Chemrite Copac, Inc. to compel plaintiff Sage Products, LLC to produce text messages [56].1 The motion is fully briefed. [63, 74]. For the following reasons, the motion is granted.

Background

This is a breach-of-contract suit between Sage, a manufacturer and supplier of healthcare products, and ChemRite, a chemical manufacturer that provided certain cleaning, rinsing, and moisturizing solutions for inclusion in Sage’s products. [1] 1. ChemRite contracted with Sage to manufacture and provide Sage with mouthwash and mouth moisturizing solutions that were subject to regulation by the Food and Drug Administration (FDA). [Id.]. In June and July 2017, the FDA issued warning letters to both parties. The letter to ChemRite advised that the company had failed to maintain separate production areas and equipment for the manufacture of the products that it supplied to Sage and for other products made by ChemRite that were not subject to FDA regulation, resulting in possible adulteration of the Sage products. [1-1] 20-22. The letter to Sage advised that Sage had failed to adequately oversee ChemRite’s production of the oral-rinse solutions and raised other concerns with a

1 Bracketed numbers refer to entries on the district court docket. Referenced page numbers are taken from the CM/ECF header placed at the top of filings. Many of the exhibits submitted by the parties in support of their positions have been filed under seal. The Court has found it necessary to refer to some of those sealed filings in this decision, but the Court has attempted to do so without revealing any information that could be reasonably deemed confidential. To the extent the Court has discussed confidential information, however, the Court has done so because it is necessary to explain the path of its reasoning. See In re Specht, 622 F.3d 697, 701 (7th Cir. 2010); Union Oil Co. of Cal. v. Leavell, 220 F.3d 562, 568 (7th Cir. 2000). microbial testing method that Sage had used in connection with its oral-rinse solutions and other products. [Id.] 25-29. On August 14, 2017, Sage voluntarily initiated a global recall of all oral-hygiene products that contained the ChemRite- manufactured solutions. [1] 8.

Shortly before initiating the recall, Sage sent ChemRite a written demand for records, including a list of ingredients in the products manufactured on the affected production line. [55-2] 2-3. One year later, in September 2018, Sage issued a formal “Notice of Claim” to ChemRite, stating that Sage “will be making a claim against ChemRite . . . for past and ongoing damages with respect to the worldwide product recall announced by Sage[.]” [55-3]. Sage then filed this lawsuit in August 2019. [1]. It seeks more than $62 million in damages. [53-2] 3.

During fact discovery, ChemRite requested documents and communications relating to actions taken by Sage or its parent company, Stryker, in response to the FDA warning letters. [52] 4-5; [53-6]. The document requests defined “communicate” and “document” in very broad terms that encompassed text messages. [53-6] 3-4. Sage made ten document productions on a rolling basis during nearly two years of fact discovery. [66] 1, ¶ 5. Sage did not object to the scope of ChemRite’s requests, nor did Sage state that it had not searched for, or was withholding, communications that had occurred over text message. See [53-8] (Sage’s responses to ChemRite’s first set of document requests).

ChemRite deposed several Sage and Stryker witnesses during discovery, including Brett Simmering, Stryker’s Vice President of Quality, Regulatory, and Clinical for the Medical Division, and Sean Haley, Sage’s former Vice President of Commercial Operations. [55-4]; [55-9]. Simmering testified that he communicated by text message with at least four other Stryker executives about the global recall. [55- 4] 5-6. Shown a print-out of a text message he had exchanged with two Stryker executives, Simmering said he was “struggling to recall this conversation from nearly four years ago,” but that the message appeared to concern another executive’s opinion that only a complete recall of the affected products would satisfy the FDA. [Id.] 7-8. Emails produced during discovery show that Simmering had referred other Stryker executives to consider certain text messages he had sent about the warning letters and the recall. See [55-5] 2 (Simmering’s July 27, 2017 email sharing text messages with Michelle Jordan, Stryker’s Director of Regulatory Affairs); [55-6] 2 (Simmering’s August 8, 2017 email to three Stryker executives indicating that he had, “per my text,” “highlighted some areas in yellow to confirm dates and status”); [55-7] 2 (Simmering’s August 14, 2017 email to Chief Regulatory Specialist Renata Sila making suggestion, “per my text,” to include certain information about “the number of devices/drugs in addition to the number of cases”). For his part, Haley testified that he texted with his “staff and key associates periodically,” though the deposition excerpt filed with the Court does not make clear the subject of these text messages. [55-9] 2, 4. In mid-June 2021, with the fact discovery period set to close on July 30, 2021 [48], the parties engaged in the Local Rule 37.2 meet-and-confer process regarding ChemRite’s request that Sage supplement its document production with responsive text messages. The parties’ meet-and-confer correspondence establishes that Sage’s document productions did not include text messages from Sage or Stryker employees. E.g., [53-17] 3; [53-18] 2-4. Sage explained that it “does not maintain a repository of its employees’ text messages sent from their mobile phones and therefore has no internal ability to search the contents of such devices.” [66] 3, ¶ 15. Sage offered to search for and produce responsive text messages from July and August 2017 that had been retained by its current employees, but ChemRite rejected this offer. [Id.], ¶ 17.

Legal Standard

“In ruling on a motion to compel, the discovery standard set forth in Rule 26(b) applies.” Mendez v. City of Chicago, 18-cv-6313, 2020 WL 4736399, at *3 (N.D. Ill. Aug. 14, 2020). Rule 26 “governs the scope of civil discovery and allows parties to obtain discovery regarding any matter that is: (1) nonprivileged; (2) relevant to any party’s claim or defense; and (3) proportional to the needs of the case.” Barnes-Staples v. Murphy, Case No. 20-cv-3627, 2021 WL 1426875, at *2 (N.D. Ill. Apr. 15, 2021). “In determining the scope of discovery under Rule 26, relevance is construed broadly and is ‘not limited to issues raised by the pleadings[.]’” Id. (quoting Oppenheimer Fund, Inc. v. Sanders, 437 U.S. 340, 351 (1978)). At the same time, discovery must be proportional to the needs of the case, “considering the importance of the issues at stake in the action, the amount in controversy, the parties’ relative access to relevant information, the parties’ resources, the importance of the discovery in resolving the issues, and whether the burden or expense of the proposed discovery outweighs its likely benefit.” Fed. R. Civ. P. 26(b)(1).

Discussion

Free access — add to your briefcase to read the full text and ask questions with AI

Sage Products, LLC v. ChemRite CoPac, Inc., (N.D. Ill. 2021).

Sage Products, LLC v. ChemRite CoPac, Inc. (Sage Products, LLC v. ChemRite CoPac, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Oppenheimer Fund, Inc. v. Sanders
437 U.S. 340 (Supreme Court, 1978)
In Re Specht
622 F.3d 697 (Seventh Circuit, 2010)
Union Oil Company of California v. Dan Leavell
220 F.3d 562 (Seventh Circuit, 2000)
In re Sulfuric Acid Antitrust Litigation
231 F.R.D. 331 (N.D. Illinois, 2005)